Candel Therapeutics's total assets for Q3 2024 were $21.52M, a decrease of -18.76% from the previous quarter. CADL total liabilities were $36.77M for the fiscal quarter, a 0.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.